Figure 1From: Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores IMP3 expression in benign prostate tissue and prostate carcinoma. (A) No or weak IMP3 expression in benign prostate tissue; (B-D) IMP3 expression in primary prostate carcinoma: (B) weak, (C) moderate and (D) strong expression.Back to article page